Skip to main content
Kenneth Stoller, MD, Psychiatry, Baltimore, MD, Johns Hopkins Hospital

KennethBruceStollerMD

Psychiatry • Baltimore, MD

Addiction

Professor of Clinical Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Director, Johns Hopkins Broadway Center for Addiction; Medical Director, Behavioral Health, Johns Hopkins HealthCare, LLC

Join to view full profile

Dr. Stoller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stoller's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Psychiatry, 1992 - 1996
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1992
  • University of Maryland, College Park
    University of Maryland, College ParkBS, Zoology (University Honors Program), Summa Cum Laude, 1988

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1995 - 2025
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

  • Nyswander/Dole Award The American Association for the Treatment of Opioid Dependence, 2016
  • Nominated for “Clinical Collaboration and Teamwork Award for Clinical Excellence.” Johns Hopkins Medicine's Office of Johns Hopkins Physicians, 2015
  • Top Manager Johns Hopkins Medicine, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Office-based buprenorphine maintenance: Setting the stage for success  
    Stoller, K.B., King, V.L., Clark, M.R., Brooner, R.K., Advanced Studies in Medicine, 1/1/2006
  • DSM-III-R versus DSM-IV substance use disorders: Concordance in drug users homogeneous for chronic and severe problems  
    Stoller, K.B., King, V.L., Kidorf, M.S., Neufeld, K.S., Brooner, R.K., Addictive Disorders and Their Treatment, 1/1/2006
  • Influence of antisocial personality subtypes on drug abuse treatment response  
    King, V.L., Kidorf, M.S., Stoller, K.B., Carter, J.A., Brooner, R.K., Journal of Nervous and Mental Disease., 1/1/2001
  • Join now to see all

Books/Book Chapters

  • The American Psychiatric Publishing Textbook of Substance Abuse Treatment 
    Chapter: Buprenorphine Maintenance. 
    Strain, E.C., Stoller, K.B.Editors: Galanter, M., Kleber, H.D., Brady, K.T..American Psychiatric Publishing, Inc., Arlington, VAEdition 5th,2015
  • The American Society of Addiction Medicine Addiction Medicine Handbook 
    Chapter: Psychiatric Co-occurring Disorders. 
    Stoller, K.B.Editors: Rastegar, D. & Fingerhood M..Oxford University Press, New York, NY2015
  • Substance Dependence and Co-Occurring Psychiatric Disorders: Best Practices for Diagnosis and Clinical Treatment. 
    Chapter: Antisocial Personality Disorder in Patients with Substance Use Disorders. 
    Brooner, R.K., Disney, E.R., Neufeld, K.S., King, V.L., Kidorf, M., Stoller, K.B.Editors: Nunes, E.V., Selzer, J., Levounis, P., and Davies, B.S..Civic Research Institute, Kingston, NJ2010
  • Join now to see all

Abstracts/Posters

  • A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers.
    Stoller, K.B., Addiction Science & Clinical Practice, 1/1/2015
  • Synthetic cannabinoid use and awareness in a drug abuse treatment clinic.
    Disney, E. Stoller, K.B., Vandrey, R., Drug & Alcohol Dependence, 1/1/2015
  • Early treatment response to a “Motivated Stepped Care” approach using LAAM: Comparison with methadone study.
    Stoller, K.B., Carter, J.A., King, V.L., Kidorf, M.S,, Brooner, R.K., American Journal on Addictions, 1/1/2003
  • Join now to see all

Lectures

  • Medication Assisted Treatment: Opportunities for Community Centers. 
    San Antonio, TX - 1/1/2016
  • Transforming Addiction Treatment through Innovative Models of Care: Insights from Maryland 
    Baltimore, Maryland - 1/1/2016
  • Coordinated Buprenorphine Treatment: Supporting Maryland’s Prescribers, Expanding the Continuum of Care 
    Baltimore, Maryland - 1/1/2015
  • Join now to see all

Other

  • Improving MAT Access and Quality Through Collaborative Care: The CoOP Model. 
    American Psychiatric Association sponsored national webinar for SAMHSA’s Provider Clinical Support S
    1/1/2016
  • An Opioid Treatment Model Spawns Imitators 
    Christine Vestal (The Pew Charitable Trusts/Stateline), Huffington Post, Baltimore Sun, CSPAN, Chicago Tribune, LA Times, Partnership for Drug-Free Kids, Pr
    http://www.huffingtonpost.com/entry/opioid-addiction-treatment_us_5720cf65e4b0b49df6a9b96a
    1/1/2016
  • Addressing the Prescription Opioid and Heroin Crisis 
    Michael Botticelli, Director of the White House Office of National Drug Control Policy., ATTC Messenger
    http://www.attcnetwork.org/Botticelli%20-%20MAT%20Article%20for%20ATTC%20Messenger%2020150819%20COS%20Approved%20v3.pdf
    1/1/2015
  • Join now to see all

Press Mentions

  • During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising Caseloads
    During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising CaseloadsJuly 27th, 2020
  • Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use Disorder
    Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use DisorderMay 12th, 2020
  • Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction Treatment
    Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction TreatmentOctober 2nd, 2019
  • Join now to see all

Hospital Affiliations

External Links

Dr. Kenneth Stoller, Dr. Kenneth Stoller, MD, Dr. K Stoller, Dr. Kenneth Bruce Stoller